AFFIX Labs key facts
- Operator of a chemical technology company intended to create new coating technologies and novel active formulations to help society fight communicable diseases.
- Notable investors include Oost NL, EIT RawMaterials, VP Capital (Goirle), Infinit Capital.
- Status: Privately Held (backing).
Who backs AFFIX Labs
4- ·Watch AFFIX Labs: the Monday email on marks, rounds and moves
AFFIX Labs funding rounds
No funding rounds for AFFIX Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
AFFIX Labs investors
4 investors are on record for AFFIX Labs, including Oost NL, EIT RawMaterials, VP Capital (Goirle) and Infinit Capital. By type, the record holds 2 venture capital firms and 2 family offices.
About AFFIX Labs
Operator of a chemical technology company intended to create new coating technologies and novel active formulations to help society fight communicable diseases. The company focuses on binding safe chemicals in a way that boosts their longevity and has led to products such as insect-repellent textile coating, focusing on fighting insect-borne diseases such as Malaria, Dengue, and Zika viruses, enabling companies with products to prevent the spread of communicable diseases via surface transmission or insect bite.
- Sector
- Materials and Resources
- HQ
- Helsinki, Finland
- Founded
- 2019
- Employees
- 2
- Website
- affixlabs.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
AFFIX Labs doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.